Our Clinical Trials
This is a randomised, double-blind, placebo-controlled Phase 3 registration parallel arm study to evaluate the efficacy, safety and tolerability of 60 mg Promethean Health CBD daily vs. placebo in adults experiencing mild-to-moderate pain.
This study is being conducted at our Western Sydney, Canberra, Central Coast and Brisbane sites.
Apply NowA Phase 4 Clinical Trial Comparing the Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate (FF/UMEC/VI) on Lung Function and Asthma Control in Adults with Uncontrolled Asthma Compared to the Usual Standard of Inhaled Corticosteroids/Long-Acting Beta-2 Agonists (ICS/LABA).
This study is being conducted at our Western Sydney, Centeral Coast and Brisbane sites.
Apply NowA Phase 2 Clinical Trial Evaluating the Effectiveness of Alnylam’s potential New Add-On Treatment Zilebesiran versus Placebo on Blood Pressure Control in Adults with High Cardiovascular Risk that are currently taking two or more Anti-Hypertensive Treatments.
This study is being conducted at our Western Sydney, Central Coast and Canberra sites.
Apply NowA Phase 1 study to investigate the safety and immunogenicity of an adjuvanted RSV/hMPV mRNA vaccine in adult participants aged 60 to 75 years.
This study is being conducted at our Brisbane site.
Apply NowParatus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326